Rebecca S. Kearney, PhD1,2; Chen Ji, PhD1; Jane Warwick, PhD1; Nicholas Parsons, PhD1; Jaclyn Brown, BSc1; Paul Harrison, PhD3; Jonathan Young, MBChB2; Matthew L. Costa, PhD4; for the ATM Trial Collaborators
doi : 10.1001/jama.2021.6986
JAMA. 2021;326(2):137-144
Platelet-rich plasma injections are used as a treatment for chronic midportion Achilles tendinopathy, but evidence for this treatment is limited.
Roshan John Selvaratnam, BMedSc(Hons)1,2; Euan Morrison Wallace, MD1,2; Rory Wolfe, PhD3; Peter John Anderson, PhD4,5,6; Mary-Ann Davey, DPH1,2
doi : 10.1001/jama.2021.8608
JAMA. 2021;326(2):145-153
Timely delivery of infants suspected of having fetal growth restriction (FGR) is a balance between preventing stillbirth and minimizing prematurity, particularly because many infants with suspected FGR have normal growth.
The Medicaid Outcomes Distributed Research Network (MODRN)
doi : 10.1001/jama.2021.7374
JAMA. 2021;326(2):154-164
There is limited information about trends in the treatment of opioid use disorder (OUD) among Medicaid enrollees.
Roy Xiao, MD, MS1; Vinay K. Rathi, MD, MBA1; Cary P. Gross, MD2; Joseph S. Ross, MD, MHS2; Rosh K. V. Sethi, MD, MPH3
doi : 10.1001/jama.2021.8535
JAMA. 2021;326(2):184-185
Roberto Bertollini, MD, MPH1; Hiam Chemaitelly, MSc2; Hadi M. Yassine, PhD3; Mohamed H. Al-Thani, MD1; Abdullatif Al-Khal, MD4; Laith J. Abu-Raddad, PhD2
doi : :10.1001/jama.2021.9970
JAMA. 2021;326(2):185-188
Urmimala Sarkar, MD, MPH1,2; Christine Cassel, MD2
doi : 10.1001/jama.2021.9569
JAMA. 2021;326(2):127-128
Susan Z. Yanovski, MD1; Jack A. Yanovski, MD, PhD2
doi : 10.1001/jama.2021.9486
JAMA. 2021;326(2):129-130
Kevin Fiscella, MD, MPH1; Mechelle R. Sanders, PhD1; Jennifer K. Carroll, MD, MPH2
doi : 10.1001/jama.2021.9938
JAMA. 2021;326(2):131-132
Katherine A. Termini, MD1
doi : 10.1001/jama.2021.10383
JAMA. 2021;326(2):133-134
Robert M. Silver, MD1; Nathan R. Blue, MD1
doi : 10.1001/jama.2021.8381
JAMA. 2021;326(2):135-136
Ashwani K. Singal, MD1,2; Philippe Mathurin, MD3
doi : 10.1001/jama.2021.7683
JAMA. 2021;326(2):165-176
Chelsea P. Fischer, MD, MS1,2; Karl Y. Bilimoria, MD, MS3; Amir A. Ghaferi, MD, MS4,5
doi : 10.1001/jama.2021.7510
JAMA. 2021;326(2):179-180
Kimberly A. Kho, MD1; Joseph S. Chen, MD1; Lisa M. Halvorson, MD2
doi : 10.1001/jama.2020.26436
JAMA. 2021;326(2):177-178
Christopher J. Fang, MD1; Brian W. Lester, MD1; Brian L. Hollenbeck, MD1
doi : 10.1001/jama.2021.3832
JAMA. 2021;326(2):181-182
Rita Rubin, MA
doi : 10.1001/jama.2021.9477
JAMA. 2021;326(2):118-120
Jennifer Abbasi
doi : 10.1001/jama.2021.10307
JAMA. 2021;326(2):121-123
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.10044
JAMA. 2021;326(2):125
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.10621
JAMA. 2021;326(2):125
Jennifer Abbasi
doi : 10.1001/jama.2021.10887
JAMA. 2021;326(2):124
Jennifer Abbasi
doi : 10.1001/jama.2021.10618
JAMA. 2021;326(2):124
Jennifer Abbasi
doi : 10.1001/jama.2021.10888
JAMA. 2021;326(2):124
Avani K. Patel, MD, MHA1; Alëna A. Balasanova, MD2
doi : 10.1001/jama.2020.2015
JAMA. 2021;326(2):196
Patricia A. Gabow, MD1
doi : 10.1001/jama.2021.6664
JAMA. 2021;326(2):188
Rebekah E. Gee, MD, MPH1; David Shulkin, MD2; Iyah Romm, BS3
doi : 10.1001/jama.2021.6667
JAMA. 2021;326(2):188-189
Tiffany H. Taft, PsyD1; Daniel Keszthelyi, MD, PhD2; Lukas Van Oudenhove, MD, PhD3
doi : 10.1001/jama.2021.6755
JAMA. 2021;326(2):189
Michael Camilleri, MD1
doi : 10.1001/jama.2021.6758
JAMA. 2021;326(2):189-190
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟